Clinical Trial Triple Drug Study for LF
IDA-Triple Drug Therapy Clinical Trial in Fiji
The safety of double- and triple-drug community mass drug administration for lymphatic filariasis: A multicenter, open-label, cluster-randomized study
Weil GJ, Bogus J, Christian M, Dubray C, Djuardi Y, et al.
Dosing pole recommendations for lymphatic filariasis elimination: A height-weight quantile regression modeling approach
Goss CW, O’Brian K, Dubray C, Fischer PU, Hardy M, et al.
The safety of combined triple drug therapy with ivermectin, diethylcarbamazine and albendazole in the neglected tropical diseases co-endemic setting of Fiji: A cluster randomised trial
Hardy M, Samuela J, Kama M, Tuicakau M, Romani L, et a
Email primary contact
Please log in or register